Protease-activated quantum dot probes.
暂无分享,去创建一个
Rebekah Drezek | Jiantang Sun | Jennifer L West | William W. Yu | J. West | R. Drezek | Jordan S. Miller | V. Colvin | Emmanuel Chang | William W Yu | Emmanuel Chang | Vicki L Colvin | Jordan S Miller | Jiantang Sun | Jordan S. Miller
[1] R. Ball,et al. Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues , 2005, British Journal of Cancer.
[2] Christopher M. Overall,et al. In search of partners: linking extracellular proteases to substrates , 2007, Nature Reviews Molecular Cell Biology.
[3] Roger Y. Tsien,et al. Creating new fluorescent probes for cell biology , 2003, Nature Reviews Molecular Cell Biology.
[4] H. Mori,et al. Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration , 2001, The Journal of cell biology.
[5] Dustin J Maly,et al. Peptide microarrays for the determination of protease substrate specificity. , 2002, Journal of the American Chemical Society.
[6] Michel Eichelbaum,et al. Pharmacogenomics and individualized drug therapy. , 2006, Annual review of medicine.
[7] N. Bianchi,et al. Mitochondrial genome instability in human cancers. , 2001, Mutation research.
[8] A. Alivisatos. Semiconductor Clusters, Nanocrystals, and Quantum Dots , 1996, Science.
[9] Igor L. Medintz,et al. Fluorescence resonance energy transfer between quantum dot donors and dye-labeled protein acceptors. , 2003, Journal of the American Chemical Society.
[10] G. M. Liuzzi,et al. Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies. , 2007, Trends in molecular medicine.
[11] B. Turk. Targeting proteases: successes, failures and future prospects , 2006, Nature Reviews Drug Discovery.
[12] N. Hooper. Proteases in Biology And Medicine , 2002 .
[13] John Calvin Reed. Mechanisms of apoptosis avoidance in cancer. , 1999, Current opinion in oncology.
[14] A. Marcus,et al. Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding. , 2007, Journal of the American Chemical Society.
[15] Shuming Nie,et al. Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings. , 2007, Journal of the American Chemical Society.
[16] Sherry L. Niessen,et al. Proteomic profiling of metalloprotease activities with cocktails of active-site probes , 2006, Nature chemical biology.
[17] E. Cera,et al. A simple method for the determination of individual rate constants for substrate hydrolysis by serine proteases , 2000, Protein science : a publication of the Protein Society.
[18] Th. Förster. Zwischenmolekulare Energiewanderung und Fluoreszenz , 1948 .
[19] Ralph Weissleder,et al. A dual fluorochrome probe for imaging proteases. , 2004, Bioconjugate chemistry.
[20] J. Matthew Mauro,et al. Self-Assembly of CdSe−ZnS Quantum Dot Bioconjugates Using an Engineered Recombinant Protein , 2000 .
[21] H. Mattoussi,et al. Use of quantum dots for live cell imaging , 2004, Nature Methods.
[22] David C. Lee,et al. An essential role for ectodomain shedding in mammalian development. , 1998, Science.
[23] C. Martínez-A,et al. The Matrix Metalloproteinase-9 Regulates the Insulin-like Growth Factor-triggered Autocrine Response in DU-145 Carcinoma Cells* , 1999, The Journal of Biological Chemistry.
[24] J. Lakowicz. Principles of fluorescence spectroscopy , 1983 .
[25] Kinneret Keren,et al. Dynamic imaging of protease activity with fluorescently quenched activity-based probes , 2005, Nature chemical biology.
[26] Sandra L. Schmid,et al. Regulated portals of entry into the cell , 2003, Nature.
[27] Igor L. Medintz,et al. Quantum dot bioconjugates for imaging, labelling and sensing , 2005, Nature materials.
[28] D. Ratkowsky,et al. A suitable parameterization of the Michaelis-Menten enzyme reaction. , 1986, The Biochemical journal.
[29] Ralph Weissleder,et al. Protease sensors for bioimaging , 2003, Analytical and bioanalytical chemistry.
[30] W. Webb,et al. Water-Soluble Quantum Dots for Multiphoton Fluorescence Imaging in Vivo , 2003, Science.
[31] Detection of Mitochondrial Caspase Activity in Real Time In Situ in Live Cells , 2004, Microscopy and Microanalysis.
[32] J. Post,et al. Quantum dot ligands provide new insights into erbB/HER receptor–mediated signal transduction , 2004, Nature Biotechnology.
[33] Albert Libchaber,et al. Single-molecule measurements of gold-quenched quantum dots. , 2004, Physical review letters.
[34] Kevin Barraclough,et al. I and i , 2001, BMJ : British Medical Journal.
[35] S. Weiss,et al. Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins , 1998, Cell.
[36] X. Puente,et al. Human and mouse proteases: a comparative genomic approach , 2003, Nature Reviews Genetics.
[37] T. Nann,et al. Single Quantum Dots in Silica Spheres by Microemulsion Synthesis , 2005 .
[38] X. Puente,et al. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors , 2004, Biological chemistry.
[39] Igor L. Medintz,et al. Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot–peptide conjugates , 2006, Nature materials.
[40] Igor L. Medintz,et al. Self-assembled quantum dot-peptide bioconjugates for selective intracellular delivery. , 2006, Bioconjugate chemistry.
[41] Xiaogang Peng,et al. Experimental Determination of the Extinction Coefficient of CdTe, CdSe, and CdS Nanocrystals , 2003 .
[42] B. Sheu,et al. A novel role of metalloproteinase in cancer-mediated immunosuppression. , 2001, Cancer research.
[43] S. Nie,et al. In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.
[44] K. McCoy,et al. New assay using fluorogenic substrates and immunofluorescence staining to measure cysteine cathepsin activity in live cell subpopulations , 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[45] H. Kita,et al. The role of protease activation of inflammation in allergic respiratory diseases. , 2004, The Journal of allergy and clinical immunology.
[46] Joachim O. Rädler,et al. Hydrophobic Nanocrystals Coated with an Amphiphilic Polymer Shell: A General Route to Water Soluble Nanocrystals , 2004 .
[47] D. Farley,et al. Development of an assay suitable for high-throughput screening to measure matrix metalloprotease activity. , 2003, Assay and drug development technologies.
[48] R. Weinshilboum. Inheritance and drug response. , 2003, The New England journal of medicine.
[49] J. Matthew Mauro,et al. Long-term multiple color imaging of live cells using quantum dot bioconjugates , 2003, Nature Biotechnology.
[50] Emanuel F. Petricoin,et al. Clinical Applications of Proteomics: Proteomic Pattern Diagnostics , 2002, Journal of Mammary Gland Biology and Neoplasia.
[51] W. Redd. Behavioral intervention for cancer treatment side effects. , 1994, Acta oncologica.
[52] Igor L. Medintz,et al. Self-assembled nanoscale biosensors based on quantum dot FRET donors , 2003, Nature materials.
[53] Zhenyu Ding,et al. Predicting Cancer Drug Response by Proteomic Profiling , 2006, Clinical Cancer Research.
[54] J. West,et al. Cell migration through defined, synthetic extracellular matrix analogues , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[55] Bonnie F. Sloane,et al. Lysosomal cathepsin B: correlation with metastatic potential. , 1981, Science.
[56] B. Krauskopf,et al. Proc of SPIE , 2003 .
[57] Zeev Rosenzweig,et al. Synthesis and application of quantum dots FRET-based protease sensors. , 2006, Journal of the American Chemical Society.
[58] Ralph Weissleder,et al. A novel method for imaging apoptosis using a caspase-1 near-infrared fluorescent probe. , 2004, Neoplasia.
[59] F. Luciani,et al. A mathematical model of protein degradation by the proteasome. , 2005, Biophysical journal.
[60] Shinsuke Sando,et al. A quantum dot conjugated sugar ball and its cellular uptake. On the size effects of endocytosis in the subviral region. , 2004, Journal of the American Chemical Society.
[61] N. Rosenzweig,et al. Luminescent quantum dots fluorescence resonance energy transfer-based probes for enzymatic activity and enzyme inhibitors. , 2007, Analytical chemistry.
[62] Peter Friedl,et al. Functional imaging of pericellular proteolysis in cancer cell invasion. , 2005, Biochimie.
[63] Isabelle Richard,et al. Imaging calpain protease activity by multiphoton FRET in living mice. , 2005, Journal of molecular biology.
[64] Matthew B. Johnson,et al. Large-scale synthesis of nearly monodisperse CdSe/CdS core/shell nanocrystals using air-stable reagents via successive ion layer adsorption and reaction. , 2003, Journal of the American Chemical Society.
[65] R Weissleder,et al. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. , 2000, Cancer research.
[66] Byron Ballou,et al. Noninvasive imaging of quantum dots in mice. , 2004, Bioconjugate chemistry.
[67] Vincent Noireaux,et al. In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles , 2002, Science.
[68] Jingsong Xu,et al. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo , 2001, The Journal of cell biology.
[69] Daniele Gerion,et al. Fluorescent CdSe/ZnS nanocrystal-peptide conjugates for long-term, nontoxic imaging and , 2004 .
[70] H. Verspaget,et al. Proteases as prognostic markers in cancer , 1998, BMJ.
[71] F. Blasi,et al. In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion , 1991, The Journal of cell biology.
[72] M. Lavin,et al. A sensitive fluorescent assay for measuring the cysteine protease activity of Der p 1, a major allergen from the dust mite Dermatophagoides pteronyssinus. , 1998, Molecular pathology : MP.
[73] R. Weissleder. A clearer vision for in vivo imaging , 2001, Nature Biotechnology.
[74] D. Reinhoudt,et al. Fluorescence quenching of dye molecules near gold nanoparticles: radiative and nonradiative effects. , 2002, Physical review letters.
[75] Matthew D Disney,et al. Hybridization-based unquenching of DNA hairpins on au surfaces: prototypical "molecular beacon" biosensors. , 2003, Journal of the American Chemical Society.
[76] M. Stack,et al. Comparison of vertebrate collagenase and gelatinase using a new fluorogenic substrate peptide. , 1989, The Journal of biological chemistry.
[77] M. Kris,et al. Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[78] W. Wiczk,et al. Fluorogenic peptide substrates for carboxydipeptidase activity of cathepsin B. , 2004, Acta biochimica Polonica.
[79] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[80] R. Paridaens,et al. Proteases and metastasis: clinical relevance nowadays? , 2005, Current opinion in oncology.
[81] R. Weissleder,et al. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.
[82] Erkki Ruoslahti,et al. Nanocrystal targeting in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[83] W. Birchmeier,et al. Epithelial-mesenchymal transitions in cancer progression. , 1996, Acta anatomica.
[84] S. Gambhir,et al. Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.
[85] J. Kos,et al. Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). , 1998, Oncology reports.
[86] K. Nabeshima,et al. Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity. , 1999, The American journal of pathology.
[87] International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome , 2001, Nature.
[88] J. Weinstein,et al. Biomarkers in Cancer Staging, Prognosis and Treatment Selection , 2005, Nature Reviews Cancer.
[89] A. Libchaber,et al. Single-mismatch detection using gold-quenched fluorescent oligonucleotides , 2001, Nature Biotechnology.
[90] Kenji Yamamoto,et al. Semiconductor quantum dot/albumin complex is a long-life and highly photostable endosome marker. , 2003, Biochemical and biophysical research communications.
[91] M. Tatham,et al. A fluorescence-resonance-energy-transfer-based protease activity assay and its use to monitor paralog-specific small ubiquitin-like modifier processing. , 2007, Analytical biochemistry.
[92] Jiqiu Chen,et al. Near-Infrared Fluorescent Imaging of Matrix Metalloproteinase Activity After Myocardial Infarction , 2005, Circulation.
[93] W. Yu,et al. Requirement for Specific Proteases in Cancer Cell Intravasation as Revealed by a Novel Semiquantitative PCR-Based Assay , 1998, Cell.
[94] Rüdiger Rudolf,et al. Looking forward to seeing calcium , 2003, Nature Reviews Molecular Cell Biology.
[95] G. Ginsburg,et al. The path to personalized medicine. , 2002, Current opinion in chemical biology.
[96] Ralph Weissleder,et al. Developing a peptide-based near-infrared molecular probe for protease sensing. , 2004, Bioconjugate chemistry.
[97] G Murphy,et al. A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases , 1992, FEBS letters.
[98] Shigeyoshi Itohara,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.
[99] J. Yates,et al. Direct analysis of protein complexes using mass spectrometry , 1999, Nature Biotechnology.
[100] Bonnie F. Sloane,et al. Hu/Mu ProtIn Oligonucleotide Microarray: Dual-Species Array for Profiling Protease and Protease Inhibitor Gene Expression in Tumors and Their Microenvironment , 2007, Molecular Cancer Research.
[101] M. Ozkan,et al. Nano-oncology: drug delivery, imaging, and sensing , 2006, Analytical and bioanalytical chemistry.
[102] S. Chevret,et al. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy. , 2001, The Journal of investigative dermatology.
[103] Nasreen S Jessani,et al. Activity-based probes for the proteomic profiling of metalloproteases. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[104] Hedi Mattoussi,et al. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy , 2004, Nature Medicine.
[105] S. L. Bridges. The genetics of rheumatoid arthritis: Influences on susceptibility, severity, and treatment response , 1999, Current rheumatology reports.
[106] Gilbert S. Omenn,et al. Advancement of Biomarker Discovery and Validation through the HUPO Plasma Proteome Project , 2004, Disease markers.
[107] Aaas News,et al. Book Reviews , 1893, Buffalo Medical and Surgical Journal.
[108] Sangeeta N. Bhatia,et al. Intracellular Delivery of Quantum Dots for Live Cell Labeling and Organelle Tracking , 2004 .
[109] D. Balding,et al. HLA Sequence Polymorphism and the Origin of Humans , 2006 .
[110] G. Giannelli,et al. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. , 1997, Science.
[111] Jeffrey A. Hubbell,et al. Polymeric biomaterials with degradation sites for proteases involved in cell migration , 1999 .
[112] C. Larabell,et al. Quantum dots as cellular probes. , 2005, Annual review of biomedical engineering.
[113] N. Fusenig,et al. Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.
[114] Min Zhou,et al. Quantum dots and peptides: a bright future together. , 2007, Biopolymers.